Distinct profiles between mild and severe COVID-19 patients reveal why some fight off infection easily while others don’t, guiding the development of mutation-resistant vaccines.
T-cell research reveals paths to better vaccines for COVID-19 and beyond
calendar_today
October 8, 2026
domain
texas-a-m-university